Supernus Pharmaceuticals, Inc.
SUPN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001356576
No open-market purchases or sales by Supernus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 334 institutions reported holding it in 13F filings for Q2 2026, worth $2.80B in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Supernus Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 249 | 2 | 239 | −8 |
| Shares | 57.3M | 830.2K | 57.0M | +527.4K (+0.9%) |
| Value | $1.72B | $25.0M | $1.57B | −$126.2M (−7.4%) |
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held Supernus Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pictet Asset Management Holding SA | 920,552 | $25.4M | 0.03% |
| Illinois Municipal Retirement Fund | 31,103 | $858.0K | 0.02% |
| SG Americas Securities, LLC | 28,999 | $800.0K | 0.01% |
| Comerica Bank | 27,624 | $761.6K | 0.00% |
| Royce & Associates LP | 18,750 | $516.9K | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 16,131 | $444.7K | 0.04% |
| QRG Capital Management, Inc. | 15,091 | $416.1K | 0.01% |
| HighTower Advisors, LLC | 12,477 | $341.0K | 0.00% |
| Vident Advisory, LLC | 10,952 | $301.9K | 0.01% |
| Captrust Financial Advisors | 10,359 | $285.6K | 0.00% |
| Verition Fund Management LLC | 9,805 | $270.3K | 0.00% |
| Envestnet Portfolio Solutions, Inc. | 9,515 | $262.3K | 0.00% |
| Gsa Capital Partners LLP | 7,287 | $201.0K | 0.02% |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 202 | $5.57K | 0.00% |
| LGT Financial Advisors LLC | 130 | $3.58K | 0.00% |
| Creative Planning | 128 | $3.53K | 0.00% |
| Simplex Trading, LLC | 140 | $3.00K | 0.00% |
| FinTrust Capital Advisors, LLC | 71 | $1.96K | 0.00% |
| Sunbelt Securities, Inc. | 35 | $965 | 0.00% |
| Glassman Wealth Services | 16 | $441 | 0.00% |
| Lindbrook Capital, LLC | 14 | $386 | 0.00% |
| Coppell Advisory Solutions LLC | 9 | $321 | 0.00% |
Sold out (30)
Institutions that held Supernus Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
Not filed for Q3 2023 yet (2)
Institutions that held Supernus Pharmaceuticals, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Pictet Asset Management SA | 777,962 | $23.4M |
| EA Series Trust | 52,192 | $1.57M |